Related Experiment Video
Updated: May 29, 2026

06:52
Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
Aggregation of amyloids in a cellular context: modelling and experiment
1School of Natural Sciences, Linnæus University, 391 82 Kalmar, Sweden. ran.friedman@lnu.se
The Biochemical Journal
|August 27, 2011
Summary
Amyloid diseases involve protein misfolding and aggregation. An integrative approach combining experimental and simulation studies is crucial for understanding and treating these complex protein aggregation disorders.
Area of Science:
- Biochemistry
- Biophysics
- Computational Biology
Background:
- Amyloid-related diseases are characterized by abnormal protein aggregation into fibrils.
- Understanding initial aggregation events, like amyloid-beta (Aβ) dimer formation and peptide-lipid interactions, is key.
- The complexity of aggregation and interactions with cellular components makes in vitro and in vivo studies challenging.
Purpose of the Study:
- To review recent advancements in modeling and experimental techniques for studying amyloid aggregation.
- To present an integrated view of how molecular interactions contribute to amyloid-related diseases.
- To highlight the necessity of a combined approach for a comprehensive understanding of protein aggregation.
Main Methods:
- Biophysical characterization of peptide-lipid interactions.
- Development of experimental methods for stable globular aggregate generation.
- In silico computer simulations providing molecular-level insights.
Main Results:
- Studies reveal insights into initial amyloid aggregation events, including Aβ dimer formation and interactions with lipid membranes.
- Fibril disaggregation and globular aggregate formation highlight the complexity of amyloid processes.
- Computational simulations offer atomistic details and aid in interpreting experimental findings.
Conclusions:
- Stable globular aggregates offer new avenues for studying molecular events in amyloid aggregation.
- An integrative approach combining in vitro, in silico, and experimental data is essential for understanding amyloid-related diseases.
- Further research integrating diverse methodologies will advance the comprehension and treatment of protein aggregation disorders.
Related Concept Videos
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

